Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.97
(4.91%)
CNY 8.97
(4.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -133.69 Million CNY | -142.51% |
| 2022 | 129.33 Million CNY | -38.68% |
| 2021 | 300.86 Million CNY | 208.53% |
| 2020 | 79.82 Million CNY | -11.84% |
| 2019 | 113.43 Million CNY | 21.39% |
| 2018 | 91.62 Million CNY | 78.18% |
| 2017 | 51.07 Million CNY | 141.81% |
| 2016 | 20.22 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.74 Million CNY | 94.49% |
| 2024 Q2 | 11.2 Million CNY | 1038.65% |
| 2023 Q1 | -33.99 Million CNY | -2.11% |
| 2023 Q3 | -5.18 Million CNY | 85.5% |
| 2023 Q2 | -35.74 Million CNY | -5.15% |
| 2023 FY | - CNY | -142.51% |
| 2023 Q4 | -35.11 Million CNY | -577.55% |
| 2022 Q2 | 48 Million CNY | -66.66% |
| 2022 Q4 | -33.29 Million CNY | -271.82% |
| 2022 Q1 | 143.98 Million CNY | 245.59% |
| 2022 Q3 | -8.95 Million CNY | -118.65% |
| 2022 FY | - CNY | -38.68% |
| 2021 Q1 | 101.13 Million CNY | 331.55% |
| 2021 Q2 | 88.36 Million CNY | -12.62% |
| 2021 Q3 | 38.38 Million CNY | -56.56% |
| 2021 Q4 | 41.66 Million CNY | 8.54% |
| 2021 FY | - CNY | 208.53% |
| 2020 Q3 | 13.35 Million CNY | 212.82% |
| 2020 Q1 | 41.16 Million CNY | -10.23% |
| 2020 FY | - CNY | -11.84% |
| 2020 Q4 | 23.43 Million CNY | 75.52% |
| 2020 Q2 | 4.26 Million CNY | -89.63% |
| 2019 Q4 | 45.85 Million CNY | 0.0% |
| 2019 FY | - CNY | 21.39% |
| 2019 Q1 | 15.19 Million CNY | 0.0% |
| 2018 FY | - CNY | 78.18% |
| 2017 FY | - CNY | 141.81% |
| 2016 FY | - CNY | 0.0% |